Zotefoams PLC Trading Update (4217B)
January 10 2018 - 2:00AM
UK Regulatory
TIDMZTF
RNS Number : 4217B
Zotefoams PLC
10 January 2018
Zotefoams plc
("Zotefoams" or "the Company")
Trading Update
10(th) January 2018 - Zotefoams, a world leader in cellular
materials technology, today provides a trading update following the
Company's financial year end on 31 December 2017.
Zotefoams is pleased to report continued strong trading through
to the end of the year, continuing the trend of the first three
quarters.
-- Full year revenues expected to be ahead of current market expectations
-- Adjusted profit before tax and exceptional items for the year
ending 31 December 2017 expected to be at the top end of the range
of market expectations
-- US plant construction completed, commissioning has begun with
expected hand-over to manufacturing in February
The Company expects to announce preliminary results for the year
ended 31 December 2017 on Tuesday 13 March 2018.
Commenting on the update David Stirling, Group CEO of Zotefoams,
said:
"We are delighted to report robust growth across all business
units during 2017 and, with good progress in the development of our
portfolio of future opportunities, enter 2018 with a strong order
book and confident about the future. We are excited at the
commissioning of our new capacity in Walton, USA, as well as the
continued commitment to growth demonstrated by our previously
announced GBP12m investment to boost manufacturing capacity at our
Croydon, UK, facility."
- Ends -
Enquiries:
Zotefoams plc +44 (0) 208 664 1600
David Stirling, Group
CEO
Gary McGrath, Group CFO
IFC Advisory +44 (0) 203 934 6630
Graham Herring
Miles Nolan
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular
materials technology. Using a unique manufacturing process with
environmentally friendly nitrogen expansion, Zotefoams produces and
sells lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance
foams for diverse markets worldwide. Zotefoams uses its own
cellular materials to manufacture T-FIT(R) advanced insulation for
demanding industrial markets. In addition, Zotefoams owns and
licenses patented MuCell(R) microcellular foam technology,
developed specifically for extrusion applications, from a base in
Massachusetts, USA to customers worldwide.
Zotefoams is headquartered in Croydon, UK, with additional
manufacturing sites in Kentucky and Oklahoma, USA (foam products
manufacture and conversion), Massachusetts, USA (MuCell Extrusion)
and Jiangsu Province, China (T-FIT(R)).
www.zotefoams.com
AZOTE(R), ZOTEK(R), T-FIT(R) are registered trademarks of
Zotefoams plc
MuCell(R) is a registered trademark of Trexel Inc.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTZMGGMGLZGRZZ
(END) Dow Jones Newswires
January 10, 2018 02:00 ET (07:00 GMT)
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Apr 2023 to Apr 2024